C12Y 305/04002
Adenine deaminase
Official title: Adenine deaminase (3.5.4.2)
C12Y305/04002 (Adenine deaminase) appears on 17 US grants and 74 published applications in this corpus.
Search patents in C12Y- Granted patents
- 17
- Published applications
- 74
- Assignees
- 47
- Inventors
- 186
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 2 |
| 2022 | 1 | 4 |
| 2023 | 3 | 4 |
| 2024 | 3 | 18 |
| 2025 | 10 | 20 |
| 2026 | 0 | 22 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Base editing enzymes23 Dec 2025US 12,503,710 B2Metagenomi, Inc.
- RNA-guided nucleases and active fragments and variants thereof and methods of use18 Nov 2025US 12,473,539 B2Life Edit Therapeutics, Inc.
- RNA-guided nucleases and active fragments and variants thereof and methods of use7 Oct 2025US 12,435,325 B2Life Edit Therapeutics, Inc.
- Methods and compositions for modification of protospacer adjacent motif specificity of CAS12A30 Sep 2025US 12,428,636 B1Pairwise Plants Services, Inc.
- Nucleobase editors and methods of use thereof16 Sep 2025US 12,416,001 B2Ohio State Innovation Foundation
- Base editing approaches to treat abca4-associated stargardt disease8 Oct 2026US 2026/0306670 A1Massachusetts Eye and Ear Infirmary
- System, Kit, and Method for Continuous Directed Evolution8 Oct 2026US 2026/0308569 A1The Board of Trustees of the University of Illinois
- Evolved adenine deaminases and rna-guided nuclease fusion proteins with internal insertion sites and methods of use1 Oct 2026US 2026/0297552 A1Life Edit Therapeutics, Inc.
- Ultracompact precision editing systems and uses thereof3 Sep 2026US 2026/0258382 A1Mammoth Biosciences, Inc.
- Optimized maize coding sequences20 Aug 2026US 2026/0242817 A1Inari Agriculture Technology, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.